2-[(2R,5S)-5-Ethenyl-5-methyloxolan-2-yl]propan-2-ol
Common Name: |
2-[(2R,5S)-5-Ethenyl-5-methyloxolan-2-yl]propan-2-ol |
IUPAC Name: |
2-[(2R,5S)-5-ethenyl-5-methyloxolan-2-yl]propan-2-ol |
Molecular Formula: |
C10H18O2 |
SMILES: |
CC1(CCC(O1)C(C)(C)O)C=C |
Inchi: |
1S/C10H18O2/c1-5-10(4)7-6-8(12-10)9(2,3)11/h5,8,11H,1,6-7H2,2-4H3/t8-,10-/m1/s1 |
Inchi Key: |
BRHDDEIRQPDPMG-PSASIEDQSA-N |
Cas No: |
5989-33-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
170.25 |
Mass (g/mol) |
170.131 |
Molar Refractivity |
49.92 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
29.46 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
188.00 to 192.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.021 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.80 |
LogP |
1.881 |
iLOGP |
2.45 |
XLOGP3 |
2.43 |
WLOGP |
1.88 |
MLOGP |
1.38 |
ESOL Log S |
-2.29 |
ESOL Solubility (mg/ml) |
0.864 |
ESOL Solubility (mol/l) |
0.005 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.69 |
Ali Solubility (mg/ml) |
0.35 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.56 |
Silicos-IT Solubility (mg/ml) |
4.66 |
Silicos-IT Solubility (mol/l) |
0.03 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.61 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.903 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.443 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |